Blood test could predict transplant complication years in advance
NCT ID NCT07539220
First seen Apr 25, 2026 · Last updated May 07, 2026 · Updated 4 times
Summary
This study looks for proteins in the blood that can help doctors predict if a patient will develop chronic graft-versus-host disease (cGVHD) after a stem cell transplant. Researchers will analyze blood samples from 1500 transplant recipients to build a model that combines these protein markers with patient history. The goal is to catch cGVHD earlier, especially when symptoms are hard to spot, so treatment can start sooner.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.